Category: National MS Society Related

Researchers are committed to finding solutions for everyone affected by MS — the very people who hold the key to the answers.

 Information provided by:   Paige B. Dalton, JD – Manager, Healthcare Provider Engagement  National Multiple Sclerosis Society Professional Resource Center : National…

Stuart Schlossman

Generic and Biosimilar Medications for MS

 Generics and biosimilars are follow-on medications. A generic is a follow-on medication to a brand medication and a biosimilar is…

Stuart Schlossman

What does the Inflation Reduction Act mean for you?

 September 12, 2023 Last year, President Biden signed the Inflation Reduction Act into law. Many changes are going to occur…

Stuart Schlossman

Read about the Pathways to CURES for MS

We’ve Never Been Closer The National Multiple Sclerosis Society is bringing the world together to cure MS  for every single person —…

Stuart Schlossman

Global Summit Reviews Advances and Opportunities for Strategic Collaborations to Speed Pathways to MS Cures

Pathways to Cures Global Summit  I (Stuart Schlossman) was fortunate to have been asked, and to have attended this Global…

Stuart Schlossman

MS and Care Partnership: Tips and Inspiration

 Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…

Stuart Schlossman

Pathways to cures for multiple sclerosis: A research roadmap

 First published online March 2022 Bruce F Bebo, Jr Bruce.Bebo@NMSS.org, Mark Allegretta, […], and on behalf of the National MS Society’s Scientific Advisory Committee and Pathways…

Stuart Schlossman

Finding Resources for the MS Community

  Use the tools on this page to find resources and providers near you. If you need guidance, see our category guides.…

Stuart Schlossman

Multiple Sclerosis Activists Play Key Role in Passage of Meaningful Prescription Drug and Health Insurance Legislation

  On August 12, the U.S. House voted to pass the Inflation Reduction Act, following the U.S. Senate’s passage of…

Stuart Schlossman

New Study Confirms the High Costs of MS to Individuals and the U.S. Economy — (“The Economic Burden of Multiple Sclerosis in the U.S.”)

  April 13, 2022 A new study, commissioned by the National MS Society, shows that for the nearly 1 million people…

Stuart Schlossman

Categories

Latest Blog Posts